DAYNART LIMITED
Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total assets | £4.40M | £3.20M |
| Current assets | £330.0k | £1.19M |
| Net assets | £3.57M | £2.42M |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
- • 1 accounts
- • 1 capital
- • 1 confirmation-statement
Corporate timeline (19 events)Click to expand
- 2025-12-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-12-18📄capital-allotment-sharescapital · SH01
- 2024-09-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-12-19📄capital-allotment-sharescapital · SH01
- 2023-10-06📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-12-19📄capital-allotment-sharescapital · SH01
- 2022-09-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-07-18📄change-person-director-company-with-change-dateofficers · CH01
- 2022-07-18📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2022-05-17📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2021-12-14📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-12-16📄change-person-director-company-with-change-dateofficers · CH01
- 2020-12-16📄change-person-director-company-with-change-dateofficers · CH01
- 2020-09-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-09-06📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-02-27📄gazette-filings-brought-up-to-dategazette · DISS40
- 2019-02-26📄gazette-notice-compulsorygazette · GAZ1
- 2012-12-04🏢Company incorporatedAs DAYNART LIMITED
- 2012-12-04➕HUSSAIN, Ammad, Dr. appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 13 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 13 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr. Ammad Hussain Individual · British · DOB 09/1984 · age 42 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · AB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| BEFRIEND A CHILD→ SC299928 · est 2006 · no financials extracted | — | — | — | — | 20y | — | — |
| BETA HEALTH CARE SOLUTIONS LIMITED→ SC838317 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| CHERRY BLOSSOM CHILDREN’S RESIDENTIAL HOME LTD→ SC667800 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| CITI AESTHETICS LIMITED→ SC658655 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| CLAREMONT ANAESTHESIA LIMITED→ SC809858 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| CONTINUITY CARE SCOTLAND LTD→ SC626674 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| COVE SMILE SOLUTIONS LTD→ SC876606 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| CREATE ABERDEEN→ SC380533 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| CTEV INITIATIVE LIMITED→ SC704847 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| DB OCCUPATIONAL HEALTH LTD→ SC849698 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| DEESIDE CARDIOLOGY LTD→ SC839221 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| DEESIDE PRIMARY CARE DERMATOLOGY LIMITED→ SC559002 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.